Neutrogena Light Therapy Acne Mask+

K180847 · Johnson & Johnson Consumer, Inc. · OLP · Jun 19, 2018 · General, Plastic Surgery

Device Facts

• Record ID: K180847
• Device Name: Neutrogena Light Therapy Acne Mask+
• Applicant: Johnson & Johnson Consumer, Inc.
• Product Code: OLP · General, Plastic Surgery
• Decision Date: Jun 19, 2018
• Decision: SESE
• Submission Type: Traditional
• Regulation: 21 CFR 878.4810
• Device Class: Class 2
• Attributes: Therapeutic

Intended Use

The Neutrogena Light Therapy Acne Mask+ is intended to emit energy in the red and blue region of the spectrum, specifically indicated to treat mild to moderate acne on the face.

Device Story

The Neutrogena Light Therapy Acne Mask+ is an OTC wearable device for home use. It utilizes non-coherent light-emitting diode (LED) technology in the blue (425-450nm) and red (620-640nm) spectrums. Blue light targets acne-causing bacteria; red light reduces inflammation. The user wears the mask like glasses and initiates a 10-minute treatment session via an integrated button on a rechargeable module. The device features an automatic shut-off after 10 minutes. The module is recharged via micro-USB. The device provides a non-invasive therapeutic regimen for acne management, allowing patients to self-administer light therapy at home.

Clinical Evidence

Bench testing only. No clinical data provided. Performance evaluation included electrical safety (IEC 60601-1), home healthcare environment requirements (IEC 60601-1-11), electromagnetic compatibility (IEC 60601-1-2), usability (IEC 60601-1-6), photobiological safety (IEC 62471), battery safety (IEC 62133-1), and biocompatibility (ISO 10993-1). A Human Factors evaluation was conducted per FDA guidance.

Technological Characteristics

Non-coherent LED light source (Blue 425-450nm, Red 620-640nm). Powered by rechargeable Ni-MH batteries. Form factor is a wearable mask with an integrated control module. Biocompatible medical-grade plastic applied parts. Connectivity via micro-USB for charging. Standards: IEC 60601-1, IEC 60601-1-11, IEC 60601-1-2, IEC 60601-1-6, IEC 60601-2-57, IEC 62471, IEC 62133-1, ISO 10993-1.

Indications for Use

Indicated for patients with mild to moderate acne on the face.

Regulatory Classification

Identification

(1) A carbon dioxide laser for use in general surgery and in dermatology is a laser device intended to cut, destroy, or remove tissue by light energy emitted by carbon dioxide.(2) An argon laser for use in dermatology is a laser device intended to destroy or coagulate tissue by light energy emitted by argon.

Predicate Devices

• Pulsaderm Acne Mask 28 (K170111)

Reference Devices

• Illumask Acne Light Therapy (K123999)

Submission Summary (Full Text)

{0}------------------------------------------------

Image /page/0/Picture/0 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, which is a blue square with the letters "FDA" in white. To the right of the blue square is the text "U.S. FOOD & DRUG ADMINISTRATION" in blue.

June 19, 2018

Johnson & Johnson Consumer Inc. Timothy Kline Associate Manager, Regulatory Affairs 7050 Camp Hill Rd Fort Washington, Pennsylvania 19034

Re: K180847

Trade/Device Name: Neutrogena Light Therapy Acne Mask+ Regulation Number: 21 CFR 878.4810 Regulation Name: Laser Surgical Instrument For Use In General And Plastic Surgery And In Dermatology Regulatory Class: Class II Product Code: OLP Dated: March 30, 2018 Received: April 2, 2018

Dear Timothy Kline:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803); good

{1}------------------------------------------------

manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm.

For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/) and CDRH Learn (http://www.fda.gov/Training/CDRHLearn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (http://www.fda.gov/DICE) for more information or contact DICE by email ([e-mail]) or phone [phone] or 301-796-7100).

Sincerely.

# Jennifer R. Stevenson -S3

For Binita S. Ashar, M.D., M.B.A., F.A.C.S. Director Division of Surgical Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

# Indications for Use

510(k) Number (if known) K180847

#### Device Name

Neutrogena Light Therapy Acne Mask+

Indications for Use (Describe)

The Neutrogena Light Therapy Acne Mask+ is intended to emit energy in the red and blue region of the spectrum, specifically indicated to treat mild to moderate acne on the face.

Prescription Use (Part 21 CFR 801 Subpart D)

|X | Over-The-Counter Use (21 CFR 801 Subpart C)

#### CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

#### *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.*

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

> Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff [e-mail]

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

{3}------------------------------------------------

#### ട. 510(K) SUMMARY

# 510(k) Summary

### General Information

JOHNSON & JOHNSON CONSUMER INC. Skillman, NJ 08558 Contact Person: Timothy Kline Email: [e-mail] Telephone: [phone] FAX: [phone] Summary Preparation Date: March 16, 2018

### Device

Common Name: Acne Light Therapy System Classification Name: Over the Counter powered Light Based Laser for Acne Classification Regulation: 21 CFR 878.4810 Classification Panel: General and Plastic Surgery Product Code: OLP

### Predicate Devices:

Predicate Device(s): Pulsaderm Acne Mask 28 (K170111) Reference Device(s): Illumask Acne Light Therapy (K123999)

### Device Description:

The Light Therapy Acne Mask + uses a known light emitting diode (LED) therapy, noncoherent light, in the red and blue range to treat mild to moderate acne bearing similar methods of operation, treatment regimen, and the ability to be recharged as the predicate K170111. The reference device bears the same technological characteristics including anatomical design and biocompatible materials as the Light Therapy Acne Mask +.

Consistent with the intended use of the predicate and reference device, the Light Therapy Acne Mask + uses blue light to kill acne causing bacteria and the red light to decrease inflammation. The user wears the mask over their face, like a pair of glasses, and presses the button on the integrated module - holding for one second - to initiate the treatment. The device has a continuous working time of 10 minutes and shuts off automatically. Each use counts as a single dose. The module contains rechargeable batteries. The module is then recharged prior to the next treatment via a micro USB cable.

### Indications for Use:

The Light Therapy Acne Mask + is intended to emit energy in the red and blue region of the spectrum, specifically indicated to treat mild to moderate acne on the face.

### Technological Characteristics and substantial equivalence:

The Light Therapy Acne Mask+ share the same methods of operation, a similar treatment regimen, and the ability to be recharged as the predicate (K170111). The reference device

{4}------------------------------------------------

(K123999) is included because the Light Therapy Acne Mask+ shares the same anatomical position to support the scientific methodology of the Light Therapy Acne Mask+.

Table 1 shows that the subject device and the predicate device share similar output and technology characteristics

Table 1. Device Comparison Table

| Feature | Subject Device | Primary Predicate (K170111) |
|----------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------|
| Classification- Regulation | 21 CFR 878.4810 | 21 CFR 878.4810 |
| Classification- Product Code | Primary: OLP - Laser surgical<br>instrument for use in general<br>and plastic surgery and in<br>dermatology. | Primary: OLP - Laser surgical<br>instrument for use in general<br>and plastic surgery and in<br>dermatology. |
| Indications for Use | Intended to emit energy in the<br>red and blue region of the<br>spectrum, specifically<br>indicated to treat mild to<br>moderate acne on the face | Intend for over the counter use<br>for the treatment of mild to<br>moderate acne |
| Environment of Use | Home | Home |
| Wavelength (nm) | Blue 425-450nm | Blue: 440+/-5nm |
| Wavelength (nm) | Red 620-640nm | Red: 630+/-5nm |
| Total 30-day Energy Dose (J/cm²) | 38.38 J/cm2 | 23.76 J/cm2 |
| Treatment Regimen | 10 minutes/day | 10 minutes/day |
| Power Source(s) | Ni-MH Batteries | Ni-MH / AA Batteries |

### Performance Data:

The bench performance tests demonstrated that the Light Therapy Acne Mask + is as safe, and as effective as the predicate device. Applicable recognized consensus standards included the following:

- . IEC 60601-1: 2005 + A1: 2012 – Medical Electrical Equipment part 1: General requirements for basic safety and essential performance

{5}------------------------------------------------

- . IEC 60601-1-11 Edition 2.0 2015-01 - Medical Electrical Equipment; part 1-11 General Requirements for Basic safety and Essential Performance - Collateral Standard: Requirements for Medical Electrical Equipment And Medical Electrical Systems Used In the Home Healthcare Environment
- . IEC 60601-1-2 Edition 4.0 2014-02 – Medical Electrical Equipment – Part 1-2: General Requirements For Basic Safety and Essential Performance - Collateral Standard: Electromagnetic Disturbances - Requirements and Tests
- IEC 60601-1-6 Edition 3.1 2013-10 Medical Electrical Equipment Part 1-6: General • Requirements For Basic Safety And Essential Performance - Collateral Standard: Usability
- . IEC 60601-2-57 Edition 1.0 2011-01 – Medical Electrical Equipment - Part 2-57: Particular Requirements For The Basic Safety And Essential Performance Of Non-Laser Light Source Equipment Intended For Therapeutic, Diagnostic, Monitoring And Cosmetic/Aesthetic Use
- . The photobiological safety of lamps and lamp systems was evaluated according to IEC 62471 first edition 2006-07. The safety requirements for portable sealed secondary cells and for batteries made from them, for use in portable applications was tested in accordance with IEC 62133-1:2012. The applied part is made from a common medical grade plastic commonly used in the OLP product code amongst other medical devices. The applied part components were assessed & evaluated for biocompatibility risk in accordance with ISO 10993-1.

A Human Factors (HF) evaluation was conducted to support the safe and effective development of the Light Therapy Acne Mask+ in accordance with "Applying Human Factors and Usability Engineering to Medical Devices" (April 2016).

# Conclusion

Based upon the analysis of the performance data, the characteristics, and the intended use of the subject and predicate device, the Light Therapy Acne Mask+ does not have any differences in the safety or efficacy as the predicate device (K170111), and therefore the subject and predicate devices are substantially equivalent.